行情

CDXC

CDXC

ChromaDex
NASDAQ

实时行情|Nasdaq Last Sale

4.100
-0.040
-0.97%
盘后: 4.100 0 0.00% 16:00 02/14 EST
开盘
4.110
昨收
4.140
最高
4.160
最低
4.060
成交量
12.97万
成交额
--
52周最高
4.950
52周最低
2.680
市值
2.43亿
市盈率(TTM)
-7.2682
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

CDXC 新闻

  • 英官员:英国不会为实现自由贸易而迎合欧盟规则
  • 中国新闻网.10分钟前
  • 亚马逊英国仓库安全问题惹担忧 三年发生事故逾600起
  • 中国新闻网.12分钟前
  • 法国阿尔斯通收购庞巴迪铁路业务
  • 新华社.32分钟前
  • 沪指震荡下跌 A股投资者数量首次突破1.6亿
  • 新浪财经.53分钟前

更多

所属板块

生物技术和医学研究
-0.16%
制药与医学研究
-0.16%

热门股票

名称
价格
涨跌幅

CDXC 简况

Chromadex Corporation and its subsidiaries ChromaDex, Inc., ChromaDex Analytics, Inc. and Spherix Consulting, Inc. provide research and quality-control products and services to the natural products industry. The Company allows its business units to discover, acquire, develop and commercialize ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. The Company operates through three segments: Ingredients, which develops, supplies and commercializes ingredient technologies; Core standards and contract services, which supplies phytochemical reference standards, which are small quantities of plant-based compounds used to research an array of attributes, reference materials and related contract services, and Scientific and regulatory consulting, which provides scientific and regulatory consulting to the clients in the food, supplement and pharmaceutical industries to manage health and regulatory risks.
展开

Webull提供Chromadex Corp的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。